Contrast Media Injectors Market (Post Covid-19 Impact) Size, Share, Growth

Posted by ankush Nikam on February 10th, 2021

Future Market Insights has published a new report titled “Contrast Media Injectors Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020–2030.” According to the report, the global contrast media injectors market is estimated to be over US$ 1.2 Bn in 2020. It is anticipated to grow at a CAGR of 4.9 % from 2020 to 2030.

The significant growth of the market can be attributed to the rising government initiative and funds. Moreover, the technological advancements in the contrast injectors from manual injectors having manifolds with stop-cocks to automated versions, providing additional accuracy and several advantages are boosting the contrast media injectors market. Contrast media injectors have wide range of applications including diagnostic and interventional procedures. Major players in this region are focusing on entering into a collaboration, partnership and launching new products to strengthen their foothold in this market. For instance, Bayer launched, Medrad Stellant Flex CT injection system, a user-driven system that requires minimal technologist training and automation.

Some of the prominent players in the Contrast Media Injector Market include:

Bayer AG, Bracco, Guerbet Group, Shenzhen Anke High-tech Co., Ltd., Nemoto Kyorindo Co., Ltd., Takasago Electric, Inc., Shenzhen Seacrown Electromechanical Co,. Ltd., ulrich GmbH & Co. KG, MEDTRON AG and APOLLO RT Co. Ltd.

According to World Health Organization, cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. This burden of cancer can also be reduced through early detection of cancer. Radiology imaging techniques can be used for detection of such cases including Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Positron Emission Tomography (PET) among others. Rising adoption and use of imaging techniques in detection of chronic disease with the help of contrast media/ Contrast agents in turn is anticipated to drive the growth of the global contrast media injectors.

Moreover, technological advancements in the contrast media injector technology to make it increasing patient safety. For instance, in 2018, Guerbet Group, launched a new multi-patient solution OptiVantage syringe-based injector. OptiVantage is a dual-head contrast delivery injector for X-Ray procedures which is designed to keep pace with increasing CT scanner speeds, while also supporting more complex injection protocols.

The Contrast Media Injector Market is segmented on the basis of Product, Modality, Cancer Type, End-Users and region. 

By Product:

• Angiographic Injectors
• Computed Tomography (CT) Injectors
• Magnetic Resonance Imaging (MRI) Injectors 

End Users

• Hospital
• Ambulatory Surgical centers
• Diagnostics Centers

Have any query? Inquiry about report: https://www.futuremarketinsights.com/ask-question/rep-gb-823

Research Approach

As a standard protocol at FMI, all research assignments go through the following rigorous processes.

• Secondary Research
• Primary Research
• Market Size Estimation & Forecasting
• Data Validation & Triangulation
• Report Generation

Table of Contents

1. INTRODUCTION
1. Market Definition
2. Market Classification
3. Geographic Scope
4. Years Considered for the Study: Historical Years – 2017 & 2018; Base Year – 2019; Forecasted Years – 2020 to 2030
5. Currency Used
2. RESEARCH METHODOLOGY
1. Research Framework
2. Data Collection Technique
3. Data Sources
4. Market Estimation Methodology
5. Data Validation and Triangulation
3. ABSTRACT OF THE STUDY
4. MARKET DYNAMICS ASSESSMENT
1. Overview
2. Drivers
3. Barriers/Challenges
4. Opportunities

And So On…